ADAS 3D

by Adas3D Medical S.L  · Based in Spain → — Fibrosis Imaging for the EP Lab
Cardiology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

ADAS 3D is a medical software tool developed by Adas3D Medical S.L, specifically designed for electrophysiologists. It specializes in the post-processing of cardiovascular enhanced Magnetic Resonance (MR) images and Computed Tomography Angiography (CTA) images, which are formatted in the Digital Imaging and Communication in Medicine (DICOM) standard.

The software aids in the non-invasive calculation, quantification, and visualization of 3D cardiac imaging data, supporting a comprehensive diagnostic decision-making process for understanding cardiovascular disease. It is particularly useful for patients with myocardial scar produced by ischemic or non-ischemic heart disease.

ADAS 3D consists of two main modules: ADAS 3D LV (Left Ventricle) and ADAS 3D LA (Left Atrium). These modules automatically identify areas of fibrosis in the myocardium and create detailed 3D models of the patient’s anatomy, including adjacent heart structures. The tool helps in visualizing fibrosis, wall thickness, and surrounding anatomical structures, enabling electrophysiologists to extract key clinical information for decision-making, planning, and guidance of electrophysiology (EP) procedures.

While the software is intended to assist healthcare professionals in diagnosis, it is not meant to fully substitute their clinical judgment. It is available through platforms like the Siemens Healthineers’ Digital Marketplace, integrating with syngo.via OpenApps.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Post-processing of cardiovascular enhanced MRI and CTA images
  • Calculation, quantification, and visualization of 3D cardiac imaging data
  • Identification of fibrotic tissue in the left ventricle (ADAS 3D LV)
  • Identification of fibrotic substrate in the left atrium (ADAS 3D LA)
  • Automated segmentation for specific image sequences (AI-powered, coming soon)
  • Export of 3D models to electrophysiology (EP) navigation systems
  • Analysis from LV Enhancement: Visualization in concentric layers, detection of anatomical corridors, identification of 3D core tissue
  • Tissue characterization with automatic classification based on Image Intensity Ratio
  • Provides a roadmap to assist in EP procedures
  • DICOM image database processing

Use Cases

  • Planning electrophysiology interventions
  • Guidance during electrophysiology procedures
  • Identification of arrhythmia substrate
  • Visualization and analysis of cardiac MR and CTA images for cardiovascular disease
  • Understanding fibrosis distribution in the myocardium
  • Pre-procedural and peri-procedural clinical decision making

What Physicians Need to Know

Cardiac CT/MRI Analysis
ADAS 3D is a specialized software for electrophysiologists that extracts key information from cardiac MRI and CT images. It processes DICOM images to calculate, quantify, and visualize fibrosis and 3D heart structures. It offers modules for Left Ventricle (LV) and Left Atrium (LA) analysis, identifying fibrotic tissue, visualizing the left ventricle in concentric layers, and detecting anatomical corridors. The tool also extracts detailed heart anatomy, including coronary arteries, aorta, and esophagus, from CT scans. AI-powered automated segmentation for specific image sequences is a feature planned for a future release.
Arrhythmia Planning Support
ADAS 3D assists in planning interventions for arrhythmias like atrial fibrillation and ventricular tachycardia by helping cardiologists understand fibrotic tissue structures and visualize areas with defective electrical signals (slow conduction channels) from MRI. It supports the automatic detection of 'CHANNELS' (Protected Pathways of Intermediate Zone) for the left ventricle. This information is crucial for guiding catheter ablation procedures. However, its clinical significance for identifying arrhythmia substrates for treatment or risk stratification has not been established as an irrefutable basis for clinical diagnosis or patient treatment.
Coronary Artery Assessment
The ADAS 3D LV module can extract and visualize heart anatomy, including coronary arteries, from CT images.
Cardiac Monitoring Integration
ADAS 3D models can be exported to electrophysiology (EP) navigation systems, serving as a roadmap to guide catheter navigation during interventions. It has demonstrated integration with Stereotaxis robotic magnetic navigation technologies.
AHA/ACC Guideline Alignment
While specific AHA/ACC guideline alignment is not explicitly detailed, ADAS 3D's principles are based on clinical evidence and scientific data. The software has received FDA clearance and CE Mark certification.
Physician Tip

ADAS 3D is a valuable pre-procedural planning and intra-procedural guidance tool for electrophysiologists. Leverage its capabilities to quantify myocardial fibrosis and visualize complex 3D cardiac anatomy from MRI and CT images, which can significantly enhance the understanding of arrhythmia substrates for ablation procedures. Remember that the software is intended to assist healthcare professionals and should complement, not substitute, clinical judgment. Pay attention to the quality and resolution of input DICOM images, as they directly impact the accuracy of the generated data. Explore the upcoming AI-powered automated segmentation for potential workflow efficiencies.

ADAS 3D supports importing cardiac images in DICOM format and can export its generated 3D models and fibrosis information to various electrophysiology (EP) navigation systems. It is available in a Cvi42 integrated version and is integrated into Siemens Healthineers' syngo.via OpenApps via their Digital Marketplace. The software has also been integrated with Stereotaxis robotic magnetic navigation technologies for enhanced procedural guidance.

Details

Category Cardiology AI, Radiology & Imaging AI, Surgical AI
Pricing Contact for pricing — Not disclosed
DeploymentStand-alone software tool, can be integrated with imaging systems (e.g., Siemens Healthineers' Digital Marketplace).
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

ADAS 3D has received multiple FDA 510(k) clearances (K191125, K210850, K212421, K230803, K240791) and CE Mark certification. It is indicated for use in clinical settings to support the visualization and analysis of MR and CT images of the heart for patients with cardiovascular disease, specifically those with myocardial scar.

Integrations
EHR Not specified
Specialties Cardiology, Radiology

What the Web Says

ADAS 3D, developed by Adas3D Medical S.L., is a software designed for the visualization and analysis of enhancement in MR and CT cardiovascular images for patients with cardiovascular disease, particularly those with myocardial scar. It helps physicians identify potential sources of irregular heartbeats and provides 3D cardiac models to guide treatment, especially for ventricular tachycardia and atrial fibrillation ablation procedures. The software integrates with robotic magnetic navigation technologies, allowing physicians to use the generated images to guide therapy. While the clinical significance for identifying arrhythmia substrates for treatment or risk stratification has not been fully established, it is intended to support qualified medical professionals in clinical decision-making.

Overall: Positive

Strengths

  • Supports rapid and precise identification of problematic cardiac tissue.
  • Generates detailed three-dimensional cardiac models from preoperative cardiac MRI.
  • Can be used to define the shape and fibrosis distribution of the Left Atrium for atrial fibrillation procedures.
  • Integrates with robotic magnetic navigation technologies for guided therapy during cardiac ablation.
  • High concordance with electroanatomical mapping for myocardial tissue characterization.
  • Provides visualization and analysis of MR and CT images of the heart for cardiovascular disease.

Limitations

  • The data produced by ADAS 3D should not be used as an irrefutable basis for clinical diagnosis or patient treatment.
  • The clinical significance of using ADAS 3D to identify arrhythmia substrates for treatment or risk stratification has not been established.
  • Accuracy is dependent on the quality and resolution of the medical images processed.
  • Limited public reviews available from independent sources like Reddit, G2, or Capterra specifically for ADAS 3D Medical's product.

Based on reviews from: Cardiac Rhythm News, PubMed Central (PMC), accessdata.fda.gov, Siemens Healthineers Digital Marketplace

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ADAS 3D

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Innolitics
Q2 2026 AI/ML FDA Clearances and De Novos
ADAS 3D cardiac image post-processing software was among the AI/ML devices reviewed under the radiology panel by the FDA in Q2 2026, highlighting its role in cardiac imaging and diagnosis.
2026-07
Circulation (American Heart Association)
Interventional MRI-Guided Ablation of Left Ventricular Tachycardia | Circulation
This article from April 2026 details a case where ADAS 3D software was used to segment 3D LGE data of the left ventricle to create a scar reconstruction for MRI-guided ablation of left ventricular tachycardia.
2026-04
EP Europace (Oxford Academic)
Concordance and reliability between electroanatomical mapping using high density mapping catheter and ADAS-3D software for myocardial tissue characterization in non-ischemic cardiomyopathy patients
Published in May 2025, this study assesses the concordance and reliability of myocardial tissue characterization between ADAS 3D software and electroanatomical mapping for patients with non-ischemic cardiomyopathy.
2025-05
Adas 3D
Update on U.S. Reimbursement and Coding for 3D Predictive Cardiac Modeling (HCPCS Code C9793)
ADAS3D Medical announced an update on U.S. reimbursement and coding for 3D predictive cardiac modeling (HCPCS Code C9793) in October 2025, indicating ongoing efforts in regulatory and market access.
2025-10
Adas 3D
ADAS3D Medical Secures Chinese NMPA Approval for Software Distribution
In June 2024, ADAS3D Medical announced it secured Chinese NMPA approval for software distribution, marking a significant milestone for its expansion in the Chinese market.
2024-06
Imricor Medical Systems, Inc.
Imricor Announces Commercial Agreement to Sell ADAS 3D Medical Software as Part of its Product Suite
Imricor announced in July 2023 a non-exclusive software distribution agreement with ADAS 3D Medical to offer ADAS 3D software as part of its iCMR ablation product suite, aiming to enhance precision in cardiac imaging and diagnosis.
2023-07
EMJ (European Medical Journal)
Embedding State-of-the-Art of Cardiac Fibrosis Imaging into Standard Practice
This article from September 2021 discusses how ADAS 3D software is used for automatic detection of arrhythmic substrate, providing detailed 3D imaging for planning and guiding cardiac ablation procedures.
2021-09
Cardiac Rhythm News
First patients treated using integrated navigation technology from Stereotaxis and ADAS 3D
In November 2019, Stereotaxis and ADAS 3D Medical announced the first patients were treated using their integrated technologies for advanced preoperative substrate mapping and robotic magnetic navigation for cardiac arrhythmias.
2019-11

Videos

Product demos, reviews, and walkthroughs for ADAS 3D.

View all on YouTube

Frequently Asked Questions

ADAS 3D integrates as a post-processing software for cardiac MRI and CT images, accessible via platforms like Siemens Healthineers' Digital Marketplace. It provides 3D visualization and quantification of myocardial fibrosis and heart structures, which helps electrophysiologists plan and guide interventions by offering a detailed roadmap of the patient's anatomy and fibrotic substrate.
ADAS 3D has received FDA clearance and CE Mark certification, indicating its compliance with key medical device regulations. The software is intended for use by qualified medical professionals and emphasizes that it assists, rather than replaces, clinical judgment, aligning with responsible AI use in healthcare.
While specific direct competitors aren't detailed in the search results, alternatives might include other advanced cardiac imaging post-processing software or manual interpretation by highly specialized radiologists and cardiologists. ADAS 3D differentiates itself by offering automated segmentation (with AI features coming soon) and direct export to EP navigation systems, streamlining the workflow for electrophysiologists.
The search results indicate ADAS 3D modules can be purchased separately or together, and it can be used with floating licenses within a hospital when integrated with systems like Cvi42. Specific pricing details are not publicly available, but it's generally offered through platforms like Siemens Healthineers' Digital Marketplace, suggesting a subscription or per-use model may be available.
ADAS 3D is not intended for patients without myocardial scar, and its accuracy is dependent on the quality and resolution of the input medical images. It is designed to assist healthcare professionals in diagnosis and cannot fully substitute clinical judgment, highlighting the need for physician oversight and interpretation.
ADAS 3D is explicitly stated to be an assistive tool, intended to support qualified healthcare professionals in clinical decision-making and cannot fully substitute their clinical judgment. Physicians remain crucial for interpreting the data, making diagnoses, and deciding on treatment strategies.
While specific technical details of data security are not extensively covered in the provided information, its integration into secure ecosystems like Siemens Healthineers' Digital Marketplace implies adherence to established healthcare data security protocols. As a medical device with FDA clearance and CE Mark, it must comply with regulations concerning patient data protection.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.